Literature DB >> 11155439

Chemokines. Introduction.

K Matsushima1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11155439     DOI： 10.1007/s002810000049

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  24 in total

1.  The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.

Authors:  R M Strieter; P J Polverini; S L Kunkel; D A Arenberg; M D Burdick; J Kasper; J Dzuiba; J Van Damme; A Walz; D Marriott
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

2.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

3.  Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.

Authors:  H Kimura; Y Kasahara; K Kurosu; K Sugito; Y Takiguchi; M Terai; A Mikata; M Natsume; N Mukaida; K Matsushima; T Kuriyama
Journal:  Lab Invest       Date:  1998-05       Impact factor: 5.662

4.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

Authors:  L Boring; J Gosling; M Cleary; I F Charo
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

6.  Structure and functional expression of a human interleukin-8 receptor.

Authors:  W E Holmes; J Lee; W J Kuang; G C Rice; W I Wood
Journal:  Science       Date:  1991-09-13       Impact factor: 47.728

7.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

Authors:  T Yoshimura; K Matsushima; J J Oppenheim; E J Leonard
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

8.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

Authors:  N Sekido; N Mukaida; A Harada; I Nakanishi; Y Watanabe; K Matsushima
Journal:  Nature       Date:  1993-10-14       Impact factor: 49.962

9.  Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor.

Authors:  U E Höpken; B Lu; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

10.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

Authors:  K Matsushima; K Morishita; T Yoshimura; S Lavu; Y Kobayashi; W Lew; E Appella; H F Kung; E J Leonard; J J Oppenheim
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
View more
  3 in total

1.  A. caviae infection triggers IL-1β secretion through activating NLRP3 inflammasome mediated by NF-κB signaling pathway partly in a TLR2 dependent manner.

Authors:  Qiankun Yang; Jianguo Zhang; Feixue Liu; Huizhen Chen; Wei Zhang; Haitao Yang; Nana He; Jingquan Dong; Panpan Zhao
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

2.  CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course.

Authors:  Ewa Pius-Sadowska; Anna Niedźwiedź; Piotr Kulig; Bartłomiej Baumert; Anna Sobuś; Dorota Rogińska; Karolina Łuczkowska; Zofia Ulańczyk; Szymon Wnęk; Igor Karolak; Edyta Paczkowska; Katarzyna Kotfis; Miłosz Kawa; Iwona Stecewicz; Piotr Zawodny; Bogusław Machaliński
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

3.  The linkage of innate and adaptive immune response during granulomatous development.

Authors:  Toshihiro Ito; Judith M Connett; Steven L Kunkel; Akihiro Matsukawa
Journal:  Front Immunol       Date:  2013-01-31       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.